Loading chat...
MO SB262
Bill
Status
Introduced
2/10/2011
Primary Sponsor
Jack Goodman
Click for details
AI Summary
- Health benefit plans covering cancer chemotherapy cannot require higher copayments, deductibles, or coinsurance for orally administered anticancer medications than for intravenously administered or injected cancer medications
- Health carriers cannot achieve compliance by increasing out-of-pocket costs for intravenously administered or injected chemotherapy agents
- Health carriers may still require prior authorization and other appropriate utilization controls for any chemotherapy
- Exemptions apply to supplemental insurance policies including accident-only, specified disease, hospital, Medicare supplement, long-term care, and short-term major medical policies of six months or less
- "Health benefit plan" and "health carrier" have the same meanings as defined in section 376.1350 of Missouri law
Legislative Description
Requires health benefit plans to establish equal out-of-pocket requirements for oral anticancer medications and intravenously administered chemotherapy medications
Last Action
Voted Do Pass S Small Business, Insurance and Industry Committee
3/29/2011
Committee Referrals
Small Business, Insurance And Industry2/17/2011
Full Bill Text
No bill text available